Global Radiodermatitis Market Size, Trends & Report, Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Radiodermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global radiodermatitis market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How Big is the Radiodermatitis Market?

The global radiodermatitis market size reached US$ 481.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 597.9 Million by 2028, exhibiting a growth rate (CAGR) of 3.5% during 2023-2028.

What is Radiodermatitis?

Radiodermatitis or radiation dermatitis is a radiation-induced skin reaction caused due to overexposure to radiant energy or radiation therapy used for treating various types of cancer. It is a significant side effect of ionizing radiation on the skin during cancer treatment, disasters, nuclear attacks, and interventional radiology procedures. Some commonly used medicines and ointments for treating radiodermatitis are anti-inflammatory agents, silver leaf nylon dressing, antibiotics, corticosteroid cream, hydrophilic creams, and amifostine. They help minimize discomfort, reduce pain, prevent interruption in ongoing therapy, and improve patient care. As a result, radiodermatitis treatment solutions are widely available in hospitals, retail, and online pharmacies.

Request Free Sample Copy of This Report:

What are the growth prospects and trends in the radiodermatitis industry?

The market is primarily driven by the growing prevalence of cancer and the consequent adoption of radiotherapy treatment across the globe. In addition, the growing geriatric population and the surging need to combat the side effects of radiation therapy are contributing to the market growth.

Moreover, various non-governing organizations (NGOs) are taking initiatives to spread awareness regarding the available radiodermatitis treatment solutions representing another major growth-inducing factor. Besides this, the governments of numerous countries are implementing several policies to develop healthcare infrastructure and increase the number of clinical trials, which is providing a positive thrust to market growth.

Furthermore, the easy availability of generic drugs, the rising disposable incomes of individuals, and increasing research and development (R&D) activities conducted by key players in the field of life sciences to introduce innovative product variants and expand their product portfolio are also creating a favorable market outlook across the globe.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Antibiotics
    • Others
  • Oral
  • Dressings
    • Hydrogel and Hydrocolloid Dressings
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressings
    • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • 3M Company
  • Bausch Health Companies Inc.
  • Bayer AG
  • Charles River Laboratories International Inc.
  • ConvaTec Group plc
  • Helsinn Healthcare SA
  • ICON plc
  • Integra LifeSciences
  • Mölnlycke Health Care AB
  • Stratpharma AG.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800


Follow us on Twitter: @imarcglobal


Read Also : Operating Room Equipment Market Share & Growth Report 2023-2028

Leave a Reply

Your email address will not be published. Required fields are marked *